What is Surgical Direct?
Surgical Direct is a developer and marketer of medical products designed to enhance patient treatment efficacy for healthcare professionals. The company operates through dedicated business units focused on innovative and cost-effective solutions addressing critical healthcare needs. With a strong emphasis on research and development, efficient manufacturing, and robust customer relationships, Surgical Direct serves medical, scientific, veterinary, and diagnostic markets. The company maintains an extensive inventory of over 17,000 products across various surgical specialties, ensuring immediate delivery. Key market segments include Laparoscopy, Arthroscopy, Surgical Instrumentation, Disposable Products, and Service & Repair. The company's commitment to excellence is further evidenced by its 2006 relocation to a new North American corporate headquarters in Deland, Florida, designed to foster communication and collaboration, thereby elevating service, quality, and product delivery.
How much funding has Surgical Direct raised?
Surgical Direct has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Surgical Direct
PPP
Public-Private Partnership
What's next for Surgical Direct?
The recent strategic investment of $350K positions Surgical Direct for continued expansion and innovation within the competitive medical technology landscape. As a company with a history of substantial capital raises, indicated by its $350K total funding, Surgical Direct is likely focused on leveraging this financing to enhance its product portfolio, potentially through further research and development or strategic acquisitions. The company's mature stage suggests a focus on market penetration, operational efficiency, and solidifying its relationships with healthcare providers to meet pressing medical needs.
See full Surgical Direct company page
